Related Experiment Video
Updated: Jun 7, 2026
An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
Mind the gaps: confocal endomicroscopy showed increased density of small bowel epithelial gaps in inflammatory bowel
Julia J Liu1, Karen L Madsen, Pierre Boulanger
1Department of Medicine, Division of Gastroenterology, University of Alberta, Edmonton, Canada. julia.liu@ualberta.ca
Objectives:
Confocal endomicroscopy can be used to image intestinal mucosa. Epithelial gaps resulting from shedding of epithelial cells have been reported in patients. We hypothesize that the rate of epithelial cell shedding increases in patients with Crohn's disease, leading to more epithelial gaps and barrier dysfunction. In this study, we used probe-based confocal laser endomicroscopy to quantify epithelial cells and gaps in patients with Crohn's disease compared with controls. We also determined the density of epithelial gaps in a mouse model of inflammatory bowel disease-interleukin-10-deficient (IL-10) mice, versus the background strain using rigid probe confocal endomicroscopy.
Methods:
Probe-based confocal laser endomicroscopy of the terminal ileum of both patients with Crohn's disease and controls was performed by a single endoscopist during colonoscopy. In mice, sections of the small intestine were imaged using a rigid confocal probe. Gap density was defined as the number of epithelial gaps per 1000 cells counted.
Results:
In this study, we examined 6 controls (2 male and 4 female; median age 59 y) and 8 patients with Crohn's disease (5 male and 3 female; median age 42 y). The mean gap densities (±standard error) observed for the 2 groups were 17.7±5.6 and 117±33 gaps per 1000 cells, respectively (P<0.01). For control and IL-10 mice, the gap densities were 10.5±2.2 and 17.8±1.4 gaps per 1000 cells, respectively (P<0.01).
Conclusions:
The epithelial gap density was significantly higher in patients with Crohn's disease than controls. Gap density was also elevated in the mouse model of inflammatory bowel disease.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:26Inflammatory Bowel Disease I: Introduction
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...